Agile Therapeutics
AGRX
#10324
Rank
โ‚ฌ8.95 M
Marketcap
1,30ย โ‚ฌ
Share price
0.00%
Change (1 day)
280.59%
Change (1 year)

EPS for Agile Therapeutics (AGRX)

EPS in 2024 (TTM): -3,58ย โ‚ฌ

According to Agile Therapeutics 's latest financial reports the company's current EPS (TTM) is -3,32ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -203,52ย โ‚ฌ an increase over its 2021 EPS that were of -1.340ย โ‚ฌ.

EPS history for Agile Therapeutics from 2014 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-3,58ย โ‚ฌ
2022-203,52ย โ‚ฌ-84.81%
2021-1.340ย โ‚ฌ30%
2020-1.031ย โ‚ฌ53.85%
2019-669,86ย โ‚ฌ-32.76%
2018-996,21ย โ‚ฌ
2016-1.735ย โ‚ฌ-26.28%
2015-2.353ย โ‚ฌ21.79%
2014-1.932ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
TherapeuticsMD
TXMD
-0,13ย โ‚ฌ-96.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
0,29ย โ‚ฌ-108.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
8,97ย โ‚ฌ-369.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
6,52ย โ‚ฌ-296.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
1,48ย โ‚ฌ-144.44%๐Ÿ‡บ๐Ÿ‡ธ USA